{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:16:02Z","timestamp":1789805762426,"version":"4.0.1"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06217-9","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:58:08Z","timestamp":1789804688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shedding Light on Interaction Between Neurological Symptoms and Psychiatric Episodes in Multiple Sclerosis: Novel Hypothesis and Therapeutic Avenues"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-1504","authenticated-orcid":false,"given":"Yutaka","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"6217_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, Weinstock-Guttman B (2024) Multiple sclerosis. Lancet 403:183\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(23)01473-3","journal-title":"Lancet"},{"key":"6217_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","volume":"23","author":"B Zierfuss","year":"2024","unstructured":"Zierfuss B, Larochelle C, Prat A (2024) Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies. Lancet Neurol 23:95\u2013109. https:\/\/doi.org\/10.1016\/S1474-4422(23)00377-0","journal-title":"Lancet Neurol"},{"key":"6217_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/sclerosis2030009","volume":"2","author":"MS Patil","year":"2024","unstructured":"Patil MS, Lin LY, Marsh-Wakefield F, James EJ, Palendira M, Hawke S, Grau G (2024) Multiple sclerosis: immune cells, histopathology, and therapeutics. Sclerosis 2:117\u2013139. https:\/\/doi.org\/10.3390\/sclerosis2030009","journal-title":"Sclerosis"},{"key":"6217_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","volume":"11","author":"DH Miller","year":"2012","unstructured":"Miller DH, Chard DT, Ciccarelli O (2012) Clinically isolated syndromes. Lancet Neurol 11:157\u2013169. https:\/\/doi.org\/10.1016\/S1474-4422(11)70274-5","journal-title":"Lancet Neurol"},{"key":"6217_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/817238","volume":"2015","author":"KA McKay","year":"2015","unstructured":"McKay KA, Kwan V, Duggan T, Tremlett H (2015) Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review. Biomed Res Int 817238. https:\/\/doi.org\/10.1155\/2015\/817238","journal-title":"Biomed Res Int"},{"issue":"Pt 3","key":"6217_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/brain\/awl007","volume":"129","author":"C Confavreux","year":"2006","unstructured":"Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129(Pt 3):606\u2013616. https:\/\/doi.org\/10.1093\/brain\/awl007","journal-title":"Brain"},{"key":"6217_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","volume":"6","author":"DH Miller","year":"2007","unstructured":"Miller DH, Leary SM (2007) Primary-progressive multiple sclerosis. Lancet Neurol 6:903\u2013912. https:\/\/doi.org\/10.1016\/S1474-4422(07)70243-0","journal-title":"Lancet Neurol"},{"key":"6217_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"GBD 2016 Multiple Sclerosis Collaborators","year":"2019","unstructured":"GBD 2016 Multiple Sclerosis Collaborators (2019) Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:269\u2013285. https:\/\/doi.org\/10.1016\/S1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"key":"6217_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11101006","volume":"11","author":"PK Coyle","year":"2021","unstructured":"Coyle PK (2021) What can we learn from sex differences in MS? J Pers Med 11:1006. https:\/\/doi.org\/10.3390\/jpm11101006","journal-title":"J Pers Med"},{"key":"6217_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jnr.23955","volume":"95","author":"LC Golden","year":"2017","unstructured":"Golden LC, Voskuhl R (2017) The importance of studying sex differences in disease: the example of multiple sclerosis. J Neurosci Res 95:633\u2013643. https:\/\/doi.org\/10.1002\/jnr.23955","journal-title":"J Neurosci Res"},{"key":"6217_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106869","volume":"105","author":"L Baiamonte","year":"2026","unstructured":"Baiamonte L, Enea M, Vaccaro M, Ragonese P, Salemi G (2026) Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurology. Mult Scler Relat Disord 105:106869. https:\/\/doi.org\/10.1016\/j.msard.2025.106869","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.yfrne.2018.07.001","volume":"50","author":"MK Houtchens","year":"2018","unstructured":"Houtchens MK, Bove R (2018) A case for gender-based approach to multiple sclerosis therapeutics. Front Neuroendocrinol 50:123\u2013134. https:\/\/doi.org\/10.1016\/j.yfrne.2018.07.001","journal-title":"Front Neuroendocrinol"},{"key":"6217_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaneurol.2024.2920","volume":"81","author":"A Salter","year":"2024","unstructured":"Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA (2024) Comorbidity and disease activity in multiple sclerosis. JAMA Neurol 81:1170\u20131177. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2920","journal-title":"JAMA Neurol"},{"key":"6217_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2377-13-16","volume":"13","author":"Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis","year":"2013","unstructured":"Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (2013) Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 13:16. https:\/\/doi.org\/10.1186\/1471-2377-13-16","journal-title":"BMC Neurol"},{"key":"6217_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, Cutter G, Reider N (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 21:305\u2013317. https:\/\/doi.org\/10.1177\/1352458514564487","journal-title":"Mult Scler"},{"key":"6217_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10571-022-01234-3","volume":"43","author":"Y Nakagawa","year":"2023","unstructured":"Nakagawa Y, Yamada S (2023) The relationships among metal homeostasis, mitochondria, and locus coeruleus in psychiatric and neurodegenerative disorders: potential pathogenetic mechanism and therapeutic implications. Cell Mol Neurobiol 43:963\u2013989. https:\/\/doi.org\/10.1007\/s10571-022-01234-3","journal-title":"Cell Mol Neurobiol"},{"key":"6217_CR17","doi-asserted-by":"publisher","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","volume":"93","author":"S Binzer","year":"2019","unstructured":"Binzer S, McKay KA, Brenner P, Hillert J, Manouchehrinia A (2019) Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study. Neurology 93:e2216\u2013e2223. https:\/\/doi.org\/10.1212\/WNL.0000000000008617","journal-title":"Neurology"},{"key":"6217_CR18","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","volume":"90","author":"KA McKay","year":"2018","unstructured":"McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA et al (2018) Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology 90:e1316\u2013e1323. https:\/\/doi.org\/10.1212\/WNL.0000000000005302","journal-title":"Neurology"},{"key":"6217_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102261","volume":"44","author":"M Hanna","year":"2020","unstructured":"Hanna M, Strober LB (2020) Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord 44:102261. https:\/\/doi.org\/10.1016\/j.msard.2020.102261","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10865-007-9095-6","volume":"30","author":"K Lester","year":"2007","unstructured":"Lester K, Stepleman L, Hughes M (2007) The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 30:177\u2013186. https:\/\/doi.org\/10.1007\/s10865-007-9095-6","journal-title":"J Behav Med"},{"key":"6217_CR21","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1007\/s11010-024-05153-3","volume":"480","author":"Y Nakagawa","year":"2025","unstructured":"Nakagawa Y, Yamada S (2025) Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms. Mol Cell Biochem 480:2661\u20132676. https:\/\/doi.org\/10.1007\/s11010-024-05153-3","journal-title":"Mol Cell Biochem"},{"key":"6217_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103640","volume":"392","author":"Y Nakagawa","year":"2025","unstructured":"Nakagawa Y, Yamada S (2025) Crosstalk between inflammation, voiding dysfunction, and psychiatric symptoms: novel hypothesis and therapeutics for urinary incontinence. J Pharmacol Exp Ther 392:103640. https:\/\/doi.org\/10.1016\/j.jpet.2025.103640","journal-title":"J Pharmacol Exp Ther"},{"key":"6217_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00011-025-02163-9","volume":"75","author":"Y Nakagawa","year":"2026","unstructured":"Nakagawa Y, Yamada S (2026) Novel insights into asthma pathophysiology and pharmacological interventions: spiral of respiratory symptoms and psychiatric episodes. Inflamm Res 75:7. https:\/\/doi.org\/10.1007\/s00011-025-02163-9","journal-title":"Inflamm Res"},{"key":"6217_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11910-016-0688-8","volume":"16","author":"A Ntranos","year":"2016","unstructured":"Ntranos A, Lublin F (2016) Diagnostic criteria, classification and treatment goals in multiple sclerosis: the chronicles of time and space. Curr Neurol Neurosci Rep 16:90. https:\/\/doi.org\/10.1007\/s11910-016-0688-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6217_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105850","volume":"91","author":"F Saridas","year":"2024","unstructured":"Saridas F, Hojjati F, Alizada S, Lazrak S, Koc ER, Turan OF (2024) Effects of disease-modifying therapies on remyelination in multiple sclerosis; evaluation via visual evoked potential test. Mult Scler Relat Disord 91:105850. https:\/\/doi.org\/10.1016\/j.msard.2024.105850","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR26","doi-asserted-by":"publisher","unstructured":"Luchicchi A, Preziosa P, \u2018t Hart B (2021) Editorial: \u201cinside-out\u201d vs \u201coutside-in\u201d paradigms in multiple sclerosis etiopathogenesis. Front Cell Neurosci 15:666529. https:\/\/doi.org\/10.3389\/fncel.2021.666529","DOI":"10.3389\/fncel.2021.666529"},{"key":"6217_CR27","doi-asserted-by":"publisher","unstructured":"\u2018t Hart BA, Luchicchi A, Schenk GJ, Stys PK, Geurts JJG (2021) Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis. Ann Clin Transl Neurol 8:1709\u20131719. https:\/\/doi.org\/10.1002\/acn3.51401","DOI":"10.1002\/acn3.51401"},{"key":"6217_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12974-022-02663-z","volume":"19","author":"C Liu","year":"2022","unstructured":"Liu C, Zhu J, Mi Y, Jin T (2022) Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. J Neuroinflammation 19:298. https:\/\/doi.org\/10.1186\/s12974-022-02663-z","journal-title":"J Neuroinflammation"},{"key":"6217_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03176","volume":"9","author":"TA Patente","year":"2019","unstructured":"Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM (2019) Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy. Front Immunol 9:3176. https:\/\/doi.org\/10.3389\/fimmu.2018.03176","journal-title":"Front Immunol"},{"key":"6217_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-019-1517-1","volume":"16","author":"BM Arneth","year":"2019","unstructured":"Arneth BM (2019) Impact of B cells to the pathophysiology of multiple sclerosis. J Neuroinflammation 16:128. https:\/\/doi.org\/10.1186\/s12974-019-1517-1","journal-title":"J Neuroinflammation"},{"key":"6217_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/imm.13198","volume":"160","author":"T Gharibi","year":"2020","unstructured":"Gharibi T, Babaloo Z, Hosseini A, Marofi F, Ebrahimi-Kalan A, Jahandideh S, Baradaran B (2020) The role of B cells in the immunopathogenesis of multiple sclerosis. Immunology 160:325\u2013335. https:\/\/doi.org\/10.1111\/imm.13198","journal-title":"Immunology"},{"key":"6217_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2019.04.003","volume":"58","author":"WR Heath","year":"2019","unstructured":"Heath WR, Kato Y, Steiner TM, Caminschi I (2019) Antigen presentation by dendritic cells for B cell activation. Curr Opin Immunol 58:44\u201352. https:\/\/doi.org\/10.1016\/j.coi.2019.04.003","journal-title":"Curr Opin Immunol"},{"key":"6217_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/brain\/awac448","volume":"146","author":"SA Gauthier","year":"2023","unstructured":"Gauthier SA (2023) Location, location, location: myelin repair and proximity to ventricular CSF in multiple sclerosis. Brain 146:10\u201312. https:\/\/doi.org\/10.1093\/brain\/awac448","journal-title":"Brain"},{"key":"6217_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41\u201353. https:\/\/doi.org\/10.1038\/nrn1824","journal-title":"Nat Rev Neurosci"},{"key":"6217_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.it.2024.11.012","volume":"46","author":"M Bijnen","year":"2025","unstructured":"Bijnen M, Sridhar S, Keller A, Greter M (2025) Brain macrophages in vascular health and dysfunction. Trends Immunol 46:46\u201360. https:\/\/doi.org\/10.1016\/j.it.2024.11.012","journal-title":"Trends Immunol"},{"key":"6217_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2020.00017","volume":"14","author":"F Troili","year":"2020","unstructured":"Troili F, Cipollini V, Moci M, Morena E, Palotai M, Rinaldi V, Romano C, Ristori G et al (2020) Perivascular unit: this must be the place. The anatomical crossroad between the immune, vascular and nervous system. Front Neuroanat 14:17. https:\/\/doi.org\/10.3389\/fnana.2020.00017","journal-title":"Front Neuroanat"},{"key":"6217_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","volume":"100","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Fu Z, Kipnis J (2018) The meningeal lymphatic system: a new player in neurophysiology. Neuron 100:375\u2013388. https:\/\/doi.org\/10.1016\/j.neuron.2018.09.022","journal-title":"Neuron"},{"key":"6217_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1152\/physiol.00015.2022","volume":"37","author":"L Zhao","year":"2022","unstructured":"Zhao L, Tannenbaum A, Bakker ENTP, Benveniste H (2022) Physiology of glymphatic solute transport and waste clearance from the brain. Physiology (Bethesda) 37:349\u2013362. https:\/\/doi.org\/10.1152\/physiol.00015.2022","journal-title":"Physiology (Bethesda)"},{"key":"6217_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00372-6","volume":"19","author":"D Thompson","year":"2022","unstructured":"Thompson D, Brissette CA, Watt JA (2022) The choroid plexus and its role in the pathogenesis of neurological infections. Fluids Barriers CNS 19:75. https:\/\/doi.org\/10.1186\/s12987-022-00372-6","journal-title":"Fluids Barriers CNS"},{"key":"6217_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106054","volume":"179","author":"A Verkhratsky","year":"2023","unstructured":"Verkhratsky A, Pivori\u016bnas A (2023) Astroglia support, regulate and reinforce brain barriers. Neurobiol Dis 179:106054. https:\/\/doi.org\/10.1016\/j.nbd.2023.106054","journal-title":"Neurobiol Dis"},{"key":"6217_CR41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212121","volume":"221","author":"ME Freret","year":"2024","unstructured":"Freret ME, Boire A (2024) The anatomic basis of leptomeningeal metastasis. J Exp Med 221:e20212121. https:\/\/doi.org\/10.1084\/jem.20212121","journal-title":"J Exp Med"},{"key":"6217_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1073858418775027","volume":"25","author":"T Nakada","year":"2019","unstructured":"Nakada T, Kwee IL (2019) Fluid dynamics inside the brain barrier: current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain. Neuroscientist 25:155\u2013166. https:\/\/doi.org\/10.1177\/1073858418775027","journal-title":"Neuroscientist"},{"key":"6217_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2990.2008.00986.x","volume":"35","author":"EJ Kooi","year":"2009","unstructured":"Kooi EJ, van Horssen J, Witte ME, Amor S, B\u00f8 L, Dijkstra CD, van der Valk P, Geurts JJ (2009) Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol 35:283\u2013295. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.00986.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6217_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300073","volume":"7","author":"NS Alakhras","year":"2023","unstructured":"Alakhras NS, Kaplan MH (2023) Dendritic cells as a nexus for the development of multiple sclerosis and models of disease. Adv Biol (Weinh) 7:e2300073. https:\/\/doi.org\/10.1002\/adbi.202300073","journal-title":"Adv Biol (Weinh)"},{"key":"6217_CR45","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00281-022-00926-8","volume":"44","author":"J Smolders","year":"2022","unstructured":"Smolders J, van Luijn MM, Hsiao CC, Hamann J (2022) T-cell surveillance of the human brain in health and multiple sclerosis. Semin Immunopathol 44:855\u2013867. https:\/\/doi.org\/10.1007\/s00281-022-00926-8","journal-title":"Semin Immunopathol"},{"key":"6217_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12987-023-00441-4","volume":"20","author":"I Lazarevic","year":"2023","unstructured":"Lazarevic I, Soldati S, Mapunda JA, Rudolph H, Rosito M, de Oliveira AC, Enzmann G, Nishihara H et al (2023) The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis. Fluids Barriers CNS 20:39. https:\/\/doi.org\/10.1186\/s12987-023-00441-4","journal-title":"Fluids Barriers CNS"},{"key":"6217_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1380063","volume":"15","author":"LY Tan","year":"2024","unstructured":"Tan LY, Cunliffe G, Hogan MP, Yeo XY, Oh C, Jin B, Kang J, Park J et al (2024) Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases. Front Immunol 15:1380063. https:\/\/doi.org\/10.3389\/fimmu.2024.1380063","journal-title":"Front Immunol"},{"key":"6217_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461\u2013553. https:\/\/doi.org\/10.1152\/physrev.00011.2010","journal-title":"Physiol Rev"},{"key":"6217_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020482","volume":"9","author":"M Kunkl","year":"2020","unstructured":"Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L (2020) T helper cells: the modulators of inflammation in multiple sclerosis. Cells 9:482. https:\/\/doi.org\/10.3390\/cells9020482","journal-title":"Cells"},{"key":"6217_CR50","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/89490","volume":"4","author":"P Bezzi","year":"2001","unstructured":"Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G et al (2001) CXCR4-activated astrocyte glutamate release via TNF-\u03b1: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702\u2013710. https:\/\/doi.org\/10.1038\/89490","journal-title":"Nat Neurosci"},{"key":"6217_CR51","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1523\/JNEUROSCI.4456-04.2005","volume":"25","author":"DL Taylor","year":"2005","unstructured":"Taylor DL, Jones F, Kubota ES, Pocock JM (2005) Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25:2952\u20132964. https:\/\/doi.org\/10.1523\/JNEUROSCI.4456-04.2005","journal-title":"J Neurosci"},{"key":"6217_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fncel.2019.00355","volume":"13","author":"A Fani Maleki","year":"2019","unstructured":"Fani Maleki A, Rivest S (2019) Innate immune cells: monocytes, monocyte-derived macrophages and microglia as therapeutic targets for Alzheimer\u2019s disease and multiple sclerosis. Front Cell Neurosci 13:355. https:\/\/doi.org\/10.3389\/fncel.2019.00355","journal-title":"Front Cell Neurosci"},{"key":"6217_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1495529","volume":"16","author":"P Vermersch","year":"2025","unstructured":"Vermersch P, Airas L, Berger T, Deisenhammer F, Grigoriadis N, Hartung HP, Magyari M, Popescu V et al (2025) The role of microglia in multiple sclerosis: implications for treatment with Bruton\u2019s tyrosine kinase inhibitors. Front Immunol 16:1495529. https:\/\/doi.org\/10.3389\/fimmu.2025.1495529","journal-title":"Front Immunol"},{"key":"6217_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117538","volume":"45","author":"AMR van den Bosch","year":"2026","unstructured":"van den Bosch AMR, Khoo JH, Lu Z, Liang H, Wever D, Pu L, Eggen BJL, Uhl\u00e9n M et al (2026) Microglial states associate with lesion dynamics in multiple sclerosis. Cell Rep 45:117538. https:\/\/doi.org\/10.1016\/j.celrep.2026.117538","journal-title":"Cell Rep"},{"key":"6217_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1347286","volume":"12","author":"J Song","year":"2024","unstructured":"Song J, Xiao L, Zhang Z, Wang Y, Kouis P, Rasmussen LJ, Dai F (2024) Effects of reactive oxygen species and mitochondrial dysfunction on reproductive aging. Front Cell Dev Biol 12:1347286. https:\/\/doi.org\/10.3389\/fcell.2024.1347286","journal-title":"Front Cell Dev Biol"},{"key":"6217_CR56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s0891-5849(02)01327-8","volume":"34","author":"VC Stewart","year":"2003","unstructured":"Stewart VC, Heales SJ (2003) Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic Biol Med 34:287\u2013303. https:\/\/doi.org\/10.1016\/s0891-5849(02)01327-8","journal-title":"Free Radic Biol Med"},{"key":"6217_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042276","volume":"25","author":"A Vaglio-Garro","year":"2024","unstructured":"Vaglio-Garro A, Kozlov AV, Smirnova YD, Weidinger A (2024) Pathological interplay between inflammation and mitochondria aggravates glutamate toxicity. Int J Mol Sci 25:2276. https:\/\/doi.org\/10.3390\/ijms25042276","journal-title":"Int J Mol Sci"},{"key":"6217_CR58","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.1073\/pnas.0402765101","volume":"101","author":"MJ Craner","year":"2004","unstructured":"Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG (2004) Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+\/Ca2+ exchanger. Proc Natl Acad Sci U S A 101:8168\u20138173. https:\/\/doi.org\/10.1073\/pnas.0402765101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6217_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40478-014-0097-7","volume":"2","author":"JY Lee","year":"2014","unstructured":"Lee JY, Taghian K, Petratos S (2014) Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? Acta Neuropathol Commun 2:97. https:\/\/doi.org\/10.1186\/s40478-014-0097-7","journal-title":"Acta Neuropathol Commun"},{"key":"6217_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205\u2013217. https:\/\/doi.org\/10.1038\/nri1786","journal-title":"Nat Rev Immunol"},{"key":"6217_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines7010014","volume":"7","author":"J Correale","year":"2019","unstructured":"Correale J, Marrodan M, Ysrraelit MC (2019) Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines 7:14. https:\/\/doi.org\/10.3390\/biomedicines7010014","journal-title":"Biomedicines"},{"key":"6217_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0978-3","volume":"14","author":"CK Prajeeth","year":"2017","unstructured":"Prajeeth CK, Kronisch J, Khorooshi R, Knier B, Toft-Hansen H, Gudi V, Floess S, Huehn J et al (2017) Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties. J Neuroinflammation 14:204. https:\/\/doi.org\/10.1186\/s12974-017-0978-3","journal-title":"J Neuroinflammation"},{"key":"6217_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132091","volume":"11","author":"MY Wendimu","year":"2022","unstructured":"Wendimu MY, Hooks SB (2022) Microglia phenotypes in aging and neurodegenerative diseases. Cells 11:2091. https:\/\/doi.org\/10.3390\/cells11132091","journal-title":"Cells"},{"key":"6217_CR64","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nri3086","volume":"11","author":"K Saijo","year":"2011","unstructured":"Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775\u2013787. https:\/\/doi.org\/10.1038\/nri3086","journal-title":"Nat Rev Immunol"},{"key":"6217_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113574","volume":"42","author":"CS Baaklini","year":"2023","unstructured":"Baaklini CS, Ho MFS, Lange T, Hammond BP, Panda SP, Zirngibl M, Zia S, Himmelsbach K et al (2023) Microglia promote remyelination independent of their role in clearing myelin debris. Cell Rep 42:113574. https:\/\/doi.org\/10.1016\/j.celrep.2023.113574","journal-title":"Cell Rep"},{"key":"6217_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1199313","volume":"16","author":"K Maciak","year":"2023","unstructured":"Maciak K, Dziedzic A, Saluk J (2023) Remyelination in multiple sclerosis from the miRNA perspective. Front Mol Neurosci 16:1199313. https:\/\/doi.org\/10.3389\/fnmol.2023.1199313","journal-title":"Front Mol Neurosci"},{"key":"6217_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10571-025-01578-6","volume":"45","author":"ER Asl","year":"2025","unstructured":"Asl ER, Hosseini SE, Tahmasebi F, Bolandi N, Barati S (2025) MiR-124 and miR-155 as therapeutic targets in microglia-mediated inflammation in multiple sclerosis. Cell Mol Neurobiol 45:63. https:\/\/doi.org\/10.1007\/s10571-025-01578-6","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"6217_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2153534","volume":"18","author":"J Verreycken","year":"2022","unstructured":"Verreycken J, Baeten P, Broux B (2022) Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers. Hum Vaccin Immunother 18(7):2153534. https:\/\/doi.org\/10.1080\/21645515.2022.2153534","journal-title":"Hum Vaccin Immunother"},{"key":"6217_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01884","volume":"11","author":"Z Ran","year":"2020","unstructured":"Ran Z, Yue-Bei L, Qiu-Ming Z, Huan Y (2020) Regulatory B cells and its role in central nervous system inflammatory demyelinating diseases. Front Immunol 11:1884. https:\/\/doi.org\/10.3389\/fimmu.2020.01884","journal-title":"Front Immunol"},{"key":"6217_CR70","volume":"1","author":"N Schmitt","year":"2015","unstructured":"Schmitt N (2015) Role of T follicular helper cells in multiple sclerosis. J Nat Sci 1:e139","journal-title":"J Nat Sci"},{"key":"6217_CR71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich I, Eixarch H, Villacieros-\u00c1lvarez J, Hervera A, Cobo-Calvo \u00c1, Montalban X, Espejo C (2025) Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Ther 10:324. https:\/\/doi.org\/10.1038\/s41392-025-02415-4","journal-title":"Signal Transduct Target Ther"},{"key":"6217_CR72","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/brain\/awz144","volume":"142","author":"M Filippi","year":"2019","unstructured":"Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F et al (2019) Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142:1858\u20131875. https:\/\/doi.org\/10.1093\/brain\/awz144","journal-title":"Brain"},{"key":"6217_CR73","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1212\/wnl.54.5.1155","volume":"54","author":"JH Simon","year":"2000","unstructured":"Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54:1155\u20131160. https:\/\/doi.org\/10.1212\/wnl.54.5.1155","journal-title":"Neurology"},{"key":"6217_CR74","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archneur.64.1.76","volume":"64","author":"L B\u00f6","year":"2007","unstructured":"B\u00f6 L, Geurts JJ, van der Valk P, Polman C, Barkhof F (2007) Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 64:76\u201380. https:\/\/doi.org\/10.1001\/archneur.64.1.76","journal-title":"Arch Neurol"},{"key":"6217_CR75","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Br\u00fcck W, Parisi JE et al (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188\u20132197. https:\/\/doi.org\/10.1056\/NEJMoa1100648","journal-title":"N Engl J Med"},{"key":"6217_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2377-12-11","volume":"12","author":"BF Popescu","year":"2012","unstructured":"Popescu BF, Lucchinetti CF (2012) Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 12:11. https:\/\/doi.org\/10.1186\/1471-2377-12-11","journal-title":"BMC Neurol"},{"key":"6217_CR77","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/s1044-7431(03)00210-0","volume":"24","author":"MR Dawson","year":"2003","unstructured":"Dawson MR, Polito A, Levine JM, Reynolds R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24:476\u2013488. https:\/\/doi.org\/10.1016\/s1044-7431(03)00210-0","journal-title":"Mol Cell Neurosci"},{"key":"6217_CR78","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1750-3639.2006.00043.x","volume":"17","author":"M Albert","year":"2007","unstructured":"Albert M, Antel J, Br\u00fcck W, Stadelmann C (2007) Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 17:129\u2013138. https:\/\/doi.org\/10.1111\/j.1750-3639.2006.00043.x","journal-title":"Brain Pathol"},{"key":"6217_CR79","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ana.23693","volume":"72","author":"A Chang","year":"2012","unstructured":"Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ et al (2012) Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann Neurol 72:918\u2013926. https:\/\/doi.org\/10.1002\/ana.23693","journal-title":"Ann Neurol"},{"key":"6217_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.721376","volume":"15","author":"A Sherafat","year":"2021","unstructured":"Sherafat A, Pfeiffer F, Nishiyama A (2021) Shaping of regional differences in oligodendrocyte dynamics by regional heterogeneity of the pericellular microenvironment. Front Cell Neurosci 15:721376. https:\/\/doi.org\/10.3389\/fncel.2021.721376","journal-title":"Front Cell Neurosci"},{"key":"6217_CR81","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/932351","author":"G Disanto","year":"2010","unstructured":"Disanto G, Berlanga AJ, Handel AE, Para AE, Burrell AM, Fries A, Handunnetthi L, De Luca GC et al (2010) Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. Autoimmune Dis. https:\/\/doi.org\/10.4061\/2011\/932351","journal-title":"Autoimmune Dis"},{"key":"6217_CR82","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/eji.202149757","volume":"52","author":"B Engelhardt","year":"2022","unstructured":"Engelhardt B, Comabella M, Chan A (2022) Multiple sclerosis: immunopathological heterogeneity and its implications. Eur J Immunol 52:869\u2013881. https:\/\/doi.org\/10.1002\/eji.202149757","journal-title":"Eur J Immunol"},{"key":"6217_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fncom.2013.00163","volume":"7","author":"C Bosch-Bouju","year":"2013","unstructured":"Bosch-Bouju C, Hyland BI, Parr-Brownlie LC (2013) Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions. Front Comput Neurosci 7:163. https:\/\/doi.org\/10.3389\/fncom.2013.00163","journal-title":"Front Comput Neurosci"},{"key":"6217_CR84","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/0959-4388(94)90056-6","volume":"4","author":"DA McCormick","year":"1994","unstructured":"McCormick DA, Bal T (1994) Sensory gating mechanisms of the thalamus. Curr Opin Neurobiol 4:550\u2013556. https:\/\/doi.org\/10.1016\/0959-4388(94)90056-6","journal-title":"Curr Opin Neurobiol"},{"key":"6217_CR85","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/cells13120997","volume":"13","author":"J Viellard","year":"2024","unstructured":"Viellard J, Bouali-Benazzouz R, Benazzouz A, Fossat P (2024) Modulating neural circuits of pain in preclinical models: recent insights for future therapeutics. Cells 13:997. https:\/\/doi.org\/10.3390\/cells13120997","journal-title":"Cells"},{"key":"6217_CR86","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neubiorev.2021.06.042","volume":"128","author":"JM Phillips","year":"2021","unstructured":"Phillips JM, Kambi NA, Redinbaugh MJ, Mohanta S, Saalmann YB (2021) Disentangling the influences of multiple thalamic nuclei on prefrontal cortex and cognitive control. Neurosci Biobehav Rev 128:487\u2013510. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.06.042","journal-title":"Neurosci Biobehav Rev"},{"key":"6217_CR87","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1212\/WNL.0b013e318220abd4","volume":"77","author":"M Calabrese","year":"2011","unstructured":"Calabrese M, Rinaldi F, Mattisi I, Bernardi V, Favaretto A, Perini P, Gallo P (2011) The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 77:257\u2013263. https:\/\/doi.org\/10.1212\/WNL.0b013e318220abd4","journal-title":"Neurology"},{"key":"6217_CR88","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00415-016-8368-9","volume":"264","author":"E Hyn\u010dicov\u00e1","year":"2017","unstructured":"Hyn\u010dicov\u00e1 E, Vyhn\u00e1lek M, Kalina A, Martinkovi\u010d L, Nikolai T, Lis\u00fd J, Hort J, Meluz\u00ednov\u00e1 E et al (2017) Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis. J Neurol 264:482\u2013493. https:\/\/doi.org\/10.1007\/s00415-016-8368-9","journal-title":"J Neurol"},{"key":"6217_CR89","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.5114\/pjr\/188633","volume":"89","author":"MR Wachowski","year":"2024","unstructured":"Wachowski MR, Majos M, Milewska-J\u0119drzejczak M, G\u0142\u0105bi\u0144ski A, Majos A (2024) Brain neuroplasticity in multiple sclerosis patients in functional magnetic resonance imaging. Part 1: comparison with healthy volunteers. Pol J Radiol 89:e308\u2013e315. https:\/\/doi.org\/10.5114\/pjr\/188633","journal-title":"Pol J Radiol"},{"key":"6217_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274778","volume":"17","author":"AF Abuaf","year":"2022","unstructured":"Abuaf AF, Bunting SR, Klein S, Carroll T, Carpenter-Thompson J, Javed A, Cipriani V (2022) Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches. PLoS ONE 17:e0274778. https:\/\/doi.org\/10.1371\/journal.pone.0274778","journal-title":"PLoS ONE"},{"key":"6217_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13054","volume":"32","author":"BJ Cooze","year":"2022","unstructured":"Cooze BJ, Dickerson M, Loganathan R, Watkins LM, Grounds E, Pearson BR, Bevan RJ, Morgan BP et al (2022) The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome. Brain Pathol 32:e13054. https:\/\/doi.org\/10.1111\/bpa.13054","journal-title":"Brain Pathol"},{"key":"6217_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105834","volume":"90","author":"A Samara","year":"2024","unstructured":"Samara A, Xiang B, Judge B, Ciotti JR, Yablonskiy DA, Cross AH, Brier MR (2024) Increased periventricular thalamic damage gradient in multiple sclerosis detected by quantitative gradient echo MRI. Mult Scler Relat Disord 90:105834. https:\/\/doi.org\/10.1016\/j.msard.2024.105834","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"6217_CR93","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-025-02893-4","volume":"149","author":"C Rodriguez-Mogeda","year":"2025","unstructured":"Rodriguez-Mogeda C, Koubiyr I, Prouskas SE, Georgallidou M, van der Pol SMA, Fernandez RF, de Graaf YG, van der Werf YD et al (2025) Thalamic atrophy in multiple sclerosis is associated with tract disconnection and altered microglia. Acta Neuropathol 149:52. https:\/\/doi.org\/10.1007\/s00401-025-02893-4","journal-title":"Acta Neuropathol"},{"key":"6217_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf141","volume":"7","author":"B Zeydan","year":"2025","unstructured":"Zeydan B, Neyal N, Son J, Schwarz CG, Kendall Thomas JC, Morrison HA, Bush ML, Reid RI et al (2025) Microglia positron emission tomography and progression in multiple sclerosis: thalamus on fire. Brain Commun 7:fcaf141. https:\/\/doi.org\/10.1093\/braincomms\/fcaf141","journal-title":"Brain Commun"},{"key":"6217_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93869-7","volume":"15","author":"K Fr\u00f6hlich","year":"2025","unstructured":"Fr\u00f6hlich K, Macha K, Siedler G, Sekita A, Haupenthal D, Mrochen A, Wang R, Schembs L et al (2025) Cerebral lesions in the central pain matrix are associated with headache in multiple sclerosis. Sci Rep 15:10020. https:\/\/doi.org\/10.1038\/s41598-025-93869-7","journal-title":"Sci Rep"},{"key":"6217_CR96","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s00415-024-12277-5","volume":"271","author":"M Albergoni","year":"2024","unstructured":"Albergoni M, Pagani E, Preziosa P, Meani A, Margoni M, Rocca MA, Filippi M (2024) Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis. J Neurol 271:3378\u20133388. https:\/\/doi.org\/10.1007\/s00415-024-12277-5","journal-title":"J Neurol"},{"key":"6217_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105520","volume":"86","author":"T Santini","year":"2024","unstructured":"Santini T, Chen C, Zhu W, Liou JJ, Walker E, Venkatesh S, Farhat N, Sajewski A et al (2024) Hippocampal subfields and thalamic nuclei associations with clinical outcomes in multiple sclerosis: an ultrahigh field MRI study. Mult Scler Relat Disord 86:105520. https:\/\/doi.org\/10.1016\/j.msard.2024.105520","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR98","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH et al (2018) Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 83:210\u2013222. https:\/\/doi.org\/10.1002\/ana.25145","journal-title":"Ann Neurol"},{"key":"6217_CR99","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s00415-020-09740-4","volume":"267","author":"S Magon","year":"2020","unstructured":"Magon S, Tsagkas C, Gaetano L, Patel R, Naegelin Y, Amann M, Parmar K, Papadopoulou A et al (2020) Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis. J Neurol 267:1536\u20131546. https:\/\/doi.org\/10.1007\/s00415-020-09740-4","journal-title":"J Neurol"},{"key":"6217_CR100","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3174\/ajnr.A2430","volume":"32","author":"S Mesaros","year":"2011","unstructured":"Mesaros S, Rocca MA, Pagani E, Sormani MP, Petrolini M, Comi G, Filippi M (2011) Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol 32:1016\u20131020. https:\/\/doi.org\/10.3174\/ajnr.A2430","journal-title":"AJNR Am J Neuroradiol"},{"key":"6217_CR101","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000399","volume":"4","author":"M Pawlitzki","year":"2017","unstructured":"Pawlitzki M, Neumann J, Kaufmann J, Heidel J, Stadler E, Sweeney-Reed C, Sailer M, Schreiber S (2017) Loss of corticospinal tract integrity in early MS disease stages. Neurol Neuroimmunol Neuroinflamm 4:e399. https:\/\/doi.org\/10.1212\/NXI.0000000000000399","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"6217_CR102","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tins.2017.02.002","volume":"40","author":"H Namkung","year":"2017","unstructured":"Namkung H, Kim SH, Sawa A (2017) The insula: an underestimated brain area in clinical neuroscience, psychiatry, and neurology. Trends Neurosci 40:200\u2013207. https:\/\/doi.org\/10.1016\/j.tins.2017.02.002","journal-title":"Trends Neurosci"},{"key":"6217_CR103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.tics.2010.12.005","volume":"15","author":"TF Heatherton","year":"2011","unstructured":"Heatherton TF, Wagner DD (2011) Cognitive neuroscience of self-regulation failure. Trends Cogn Sci 15:132\u2013139. https:\/\/doi.org\/10.1016\/j.tics.2010.12.005","journal-title":"Trends Cogn Sci"},{"key":"6217_CR104","doi-asserted-by":"publisher","DOI":"10.4303\/jdar\/236017","volume":"6","author":"Y Nakagawa","year":"2017","unstructured":"Nakagawa Y (2017) Psycho-behavioral spiral of disturbances in prosocial behavior, stress response, and self-regulation in substance-related and addictive disorders. J Drug Alcohol Res 6:236017. https:\/\/doi.org\/10.4303\/jdar\/236017","journal-title":"J Drug Alcohol Res"},{"key":"6217_CR105","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2147\/JPR.S189443","volume":"12","author":"H van Ettinger-Veenstra","year":"2019","unstructured":"van Ettinger-Veenstra H, Lundberg P, Alf\u00f6ldi P, S\u00f6dermark M, Graven-Nielsen T, Sj\u00f6rs A, Engstr\u00f6m M, Gerdle B (2019) Chronic widespread pain patients show disrupted cortical connectivity in default mode and salience networks, modulated by pain sensitivity. J Pain Res 12:1743\u20131755. https:\/\/doi.org\/10.2147\/JPR.S189443","journal-title":"J Pain Res"},{"key":"6217_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135428","volume":"10","author":"M Calabrese","year":"2015","unstructured":"Calabrese M, Reynolds R, Magliozzi R, Castellaro M, Morra A, Scalfari A, Farina G, Romualdi C et al (2015) Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients. PLoS One 10:e0135428. https:\/\/doi.org\/10.1371\/journal.pone.0135428","journal-title":"PLoS One"},{"key":"6217_CR107","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1002\/hbm.24319","volume":"39","author":"PC Salamone","year":"2018","unstructured":"Salamone PC, Esteves S, Sinay VJ, Garc\u00eda-Cordero I, Abrevaya S, Couto B, Adolfi F, Martorell M et al (2018) Altered neural signatures of interoception in multiple sclerosis. Hum Brain Mapp 39:4743\u20134754. https:\/\/doi.org\/10.1002\/hbm.24319","journal-title":"Hum Brain Mapp"},{"key":"6217_CR108","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2005.09.021","volume":"245","author":"A Kutzelnigg","year":"2006","unstructured":"Kutzelnigg A, Lassmann H (2006) Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci 245:123\u2013126. https:\/\/doi.org\/10.1016\/j.jns.2005.09.021","journal-title":"J Neurol Sci"},{"key":"6217_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96132-x","volume":"11","author":"E Solana","year":"2021","unstructured":"Solana E, Martinez-Heras E, Montal V, Vilaplana E, Lopez-Soley E, Radua J, Sola-Valls N, Montejo C et al (2021) Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Sci Rep 11:16805. https:\/\/doi.org\/10.1038\/s41598-021-96132-x","journal-title":"Sci Rep"},{"key":"6217_CR110","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jmri.20564","volume":"23","author":"H Vrenken","year":"2006","unstructured":"Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA (2006) Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 23:628\u2013636. https:\/\/doi.org\/10.1002\/jmri.20564","journal-title":"J Magn Reson Imaging"},{"key":"6217_CR111","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1177\/1352458519888881","volume":"26","author":"C Gonzalez Campo","year":"2020","unstructured":"Gonzalez Campo C, Salamone PC, Rodr\u00edguez-Arriagada N, Richter F, Herrera E, Bruno D, Pagani Cassara F, Sinay V et al (2020) Fatigue in multiple sclerosis is associated with multimodal interoceptive abnormalities. Mult Scler 26:1845\u20131853. https:\/\/doi.org\/10.1177\/1352458519888881","journal-title":"Mult Scler"},{"key":"6217_CR112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nicl.2015.11.008","volume":"10","author":"O Geisseler","year":"2016","unstructured":"Geisseler O, Pflugshaupt T, Bezzola L, Reuter K, Weller D, Schuknecht B, Brugger P, Linnebank M (2016) Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients\u2019 fluency performance in a lateralised manner. Neuroimage Clin 10:89\u201395. https:\/\/doi.org\/10.1016\/j.nicl.2015.11.008","journal-title":"Neuroimage Clin"},{"key":"6217_CR113","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/176157","volume":"2012","author":"JA Kiernan","year":"2012","unstructured":"Kiernan JA (2012) Anatomy of the temporal lobe. Epilepsy Res Treat 2012:176157. https:\/\/doi.org\/10.1155\/2012\/176157","journal-title":"Epilepsy Res Treat"},{"key":"6217_CR114","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ph7121028","volume":"7","author":"Y Nakagawa","year":"2014","unstructured":"Nakagawa Y, Chiba K (2014) Role of microglial M1\/M2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) 7:1028\u20131048. https:\/\/doi.org\/10.3390\/ph7121028","journal-title":"Pharmaceuticals (Basel)"},{"key":"6217_CR115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2015.06.010","volume":"154","author":"Y Nakagawa","year":"2015","unstructured":"Nakagawa Y, Chiba K (2015) Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther 154:21\u201335. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.06.010","journal-title":"Pharmacol Ther"},{"key":"6217_CR116","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.neubiorev.2011.12.014","volume":"36","author":"CA Orsini","year":"2012","unstructured":"Orsini CA, Maren S (2012) Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev 36:1773\u20131802. https:\/\/doi.org\/10.1016\/j.neubiorev.2011.12.014","journal-title":"Neurosci Biobehav Rev"},{"key":"6217_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187915","volume":"12","author":"J Wen","year":"2017","unstructured":"Wen J, Yablonskiy DA, Salter A, Cross AH (2017) Limbic system damage in MS: MRI assessment and correlations with clinical testing. PLoS ONE 12:e0187915. https:\/\/doi.org\/10.1371\/journal.pone.0187915","journal-title":"PLoS ONE"},{"key":"6217_CR118","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3174\/ajnr.A3086","volume":"33","author":"N Bergsland","year":"2012","unstructured":"Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E et al (2012) Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 33:1573\u20131578. https:\/\/doi.org\/10.3174\/ajnr.A3086","journal-title":"AJNR Am J Neuroradiol"},{"key":"6217_CR119","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biopsych.2015.11.022","volume":"80","author":"A Colasanti","year":"2016","unstructured":"Colasanti A, Guo Q, Giannetti P, Wall MB, Newbould RD, Bishop C, Onega M, Nicholas R et al (2016) Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis. Biol Psychiatry 80:62\u201372. https:\/\/doi.org\/10.1016\/j.biopsych.2015.11.022","journal-title":"Biol Psychiatry"},{"key":"6217_CR120","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/NDT.S84602","volume":"11","author":"F Zhou","year":"2015","unstructured":"Zhou F, Zhuang Y, Wang L, Zhang Y, Wu L, Zeng X, Gong H (2015) Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study. Neuropsychiatr Dis Treat 11:1749\u20131765. https:\/\/doi.org\/10.2147\/NDT.S84602","journal-title":"Neuropsychiatr Dis Treat"},{"key":"6217_CR121","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1148\/radiol.2015150532","volume":"278","author":"MA Rocca","year":"2016","unstructured":"Rocca MA, Preziosa P, Mesaros S, Pagani E, Dackovic J, Stosic-Opincal T, Drulovic J, Filippi M (2016) Clinically isolated syndrome suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes-a 2-year MR imaging study. Radiology 278:841\u2013853. https:\/\/doi.org\/10.1148\/radiol.2015150532","journal-title":"Radiology"},{"key":"6217_CR122","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/jamaneurol.2013.1954","volume":"70","author":"M Filippi","year":"2013","unstructured":"Filippi M, Rocca MA, Horsfield MA, Hametner S, Geurts JJ, Comi G, Lassmann H (2013) Imaging cortical damage and dysfunction in multiple sclerosis. JAMA Neurol 70:556\u2013564. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1954","journal-title":"JAMA Neurol"},{"key":"6217_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231868","volume":"15","author":"B Goitia","year":"2020","unstructured":"Goitia B, Bruno D, Abrevaya S, Sede\u00f1o L, Ib\u00e1\u00f1ez A, Manes F, Sigman M, Sinay V et al (2020) The relationship between executive functions and fluid intelligence in multiple sclerosis. PLoS One 15:e0231868. https:\/\/doi.org\/10.1371\/journal.pone.0231868","journal-title":"PLoS One"},{"key":"6217_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42201-1","volume":"9","author":"O Realdon","year":"2019","unstructured":"Realdon O, Serino S, Savazzi F, Rossetto F, Cipresso P, Parsons TD, Cappellini G, Mantovani F et al (2019) An ecological measure to screen executive functioning in MS: the Picture Interpretation Test (PIT) 360\u00b0. Sci Rep 9:5690. https:\/\/doi.org\/10.1038\/s41598-019-42201-1","journal-title":"Sci Rep"},{"key":"6217_CR125","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.acn.2007.04.003","volume":"22","author":"O Santiago","year":"2007","unstructured":"Santiago O, Gu\u00e0rdia J, Casado V, Carmona O, Arbizu T (2007) Specificity of frontal dysfunctions in relapsing-remitting multiple sclerosis. Arch Clin Neuropsychol 22:623\u2013629. https:\/\/doi.org\/10.1016\/j.acn.2007.04.003","journal-title":"Arch Clin Neuropsychol"},{"key":"6217_CR126","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12974-024-03326-x","volume":"21","author":"C Barros","year":"2024","unstructured":"Barros C, Alberro A, Fernandes A (2024) Microglia and immune cells interactions in multiple sclerosis cognitive impairment: a postmortem study. J Neuroinflammation 21:332. https:\/\/doi.org\/10.1186\/s12974-024-03326-x","journal-title":"J Neuroinflammation"},{"key":"6217_CR127","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.nicl.2014.12.015","volume":"8","author":"KC Kern","year":"2015","unstructured":"Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O\u2019Connor MF, Sicotte NL (2015) Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis. Neuroimage Clin 8:440\u2013447. https:\/\/doi.org\/10.1016\/j.nicl.2014.12.015","journal-title":"Neuroimage Clin"},{"key":"6217_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.667531","volume":"12","author":"J Boscheron","year":"2021","unstructured":"Boscheron J, Ruet A, Deloire M, Charr\u00e9-Morin J, Saubusse A, Brochet B, Tourdias T, Koubiyr I (2021) Insights on the relationship between hippocampal connectivity and memory performances at the early stage of multiple sclerosis. Front Neurol 12:667531. https:\/\/doi.org\/10.3389\/fneur.2021.667531","journal-title":"Front Neurol"},{"key":"6217_CR129","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/jnp.14.1.44","volume":"14","author":"RH Benedict","year":"2002","unstructured":"Benedict RH, Bakshi R, Simon JH, Priore R, Miller C, Munschauer F (2002) Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 14:44\u201351. https:\/\/doi.org\/10.1176\/jnp.14.1.44","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6217_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.955","volume":"8","author":"E Curti","year":"2018","unstructured":"Curti E, Graziuso S, Tsantes E, Crisi G, Granella F (2018) Correlation between cortical lesions and cognitive impairment in multiple sclerosis. Brain Behav 8:e00955. https:\/\/doi.org\/10.1002\/brb3.955","journal-title":"Brain Behav"},{"key":"6217_CR131","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.janxdis.2014.03.007","volume":"28","author":"NC Jacobson","year":"2014","unstructured":"Jacobson NC, Newman MG (2014) Avoidance mediates the relationship between anxiety and depression over a decade later. J Anxiety Disord 28:437\u2013445. https:\/\/doi.org\/10.1016\/j.janxdis.2014.03.007","journal-title":"J Anxiety Disord"},{"key":"6217_CR132","doi-asserted-by":"publisher","unstructured":"Gidron, Y (2013) Trait Anxiety. In: Gellman MD, Turner JR (eds) Encyclopedia of behavioral medicine. Springer, New York, pp 1989. https:\/\/doi.org\/10.1007\/978-1-4419-1005-9_1539.","DOI":"10.1007\/978-1-4419-1005-9_1539"},{"key":"6217_CR133","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.psychotherapy.2016.70.2.203","volume":"70","author":"E Blake","year":"2016","unstructured":"Blake E, Dobson KS, Sheptycki AR, Drapeau M (2016) The relationship between depression severity and cognitive errors. Am J Psychother 70:203\u2013221. https:\/\/doi.org\/10.1176\/appi.psychotherapy.2016.70.2.203","journal-title":"Am J Psychother"},{"key":"6217_CR134","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/jpet.122.001482","volume":"385","author":"Y Nakagawa","year":"2023","unstructured":"Nakagawa Y, Yamada S (2023) Alterations in brain neural network and stress system in atopic dermatitis: novel therapeutic interventions. J Pharmacol Exp Ther 385:78\u201387. https:\/\/doi.org\/10.1124\/jpet.122.001482","journal-title":"J Pharmacol Exp Ther"},{"key":"6217_CR135","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpsychores.2012.11.006","volume":"74","author":"N Lukkahatai","year":"2013","unstructured":"Lukkahatai N, Saligan LN (2013) Association of catastrophizing and fatigue: a systematic review. J Psychosom Res 74:100\u2013109. https:\/\/doi.org\/10.1016\/j.jpsychores.2012.11.006","journal-title":"J Psychosom Res"},{"key":"6217_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022","volume":"69","author":"G Menculini","year":"2023","unstructured":"Menculini G, Gentili L, Gaetani L, Mancini A, Sperandei S, Di Sabatino E, Chipi E, Salvadori N et al (2023) Clinical correlates of state and trait anxiety in multiple sclerosis. Mult Scler Relat Disord 69:104431. https:\/\/doi.org\/10.1016\/j.msard.2022","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR137","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpsychores.2006.04.018","volume":"61","author":"TN Skerrett","year":"2006","unstructured":"Skerrett TN, Moss-Morris R (2006) Fatigue and social impairment in multiple sclerosis: the role of patients\u2019 cognitive and behavioral responses to their symptoms. J Psychosom Res 61:587\u2013593. https:\/\/doi.org\/10.1016\/j.jpsychores.2006.04.018","journal-title":"J Psychosom Res"},{"key":"6217_CR138","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","volume":"89","author":"S Rossi","year":"2017","unstructured":"Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L et al (2017) Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology 89:1338\u20131347. https:\/\/doi.org\/10.1212\/WNL.0000000000004411","journal-title":"Neurology"},{"key":"6217_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02476-0","volume":"19","author":"E Ellwardt","year":"2022","unstructured":"Ellwardt E, Muthuraman M, Gonzalez-Escamilla G, Chirumamilla VC, Luessi F, Bittner S, Zipp F, Groppa S et al (2022) Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation 19:119. https:\/\/doi.org\/10.1186\/s12974-022-02476-0","journal-title":"J Neuroinflammation"},{"key":"6217_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111278","volume":"223","author":"S Rahnemayan","year":"2025","unstructured":"Rahnemayan S, Fathalizadeh A, Behroozi M, Talebi M, Naseri A, Mehdizadehfar E (2025) FMRI insights into the neural alterations and clinical correlates in multiple sclerosis: a comprehensive overview of systematic reviews and meta-analyses. Brain Res Bull 223:111278. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111278","journal-title":"Brain Res Bull"},{"key":"6217_CR141","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac152","volume":"4","author":"L Meyer-Arndt","year":"2022","unstructured":"Meyer-Arndt L, Kuchling J, Brasanac J, Hermann A, Asseyer S, Bellmann-Strobl J, Paul F, Gold SM et al (2022) Prefrontal-amygdala emotion regulation and depression in multiple sclerosis. Brain Commun 4:fcac152. https:\/\/doi.org\/10.1093\/braincomms\/fcac152","journal-title":"Brain Commun"},{"key":"6217_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102609","volume":"47","author":"M Scholz","year":"2021","unstructured":"Scholz M, Haase R, Trentzsch K, Weidemann ML, Ziemssen T (2021) Fear of falling and falls in people with multiple sclerosis: a literature review. Mult Scler Relat Disord 47:102609. https:\/\/doi.org\/10.1016\/j.msard.2020.102609","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105506","volume":"84","author":"L Abou","year":"2024","unstructured":"Abou L, Peters J, Freire B, Sosnoff JJ (2024) Fear of falling and common symptoms of multiple sclerosis: physical function, cognition, fatigue, depression, and sleep - a systematic review. Mult Scler Relat Disord 84:105506. https:\/\/doi.org\/10.1016\/j.msard.2024.105506","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR144","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11357-019-00056-4","volume":"41","author":"R Holtzer","year":"2019","unstructured":"Holtzer R, Kraut R, Izzetoglu M, Ye K (2019) The effect of fear of falling on prefrontal cortex activation and efficiency during walking in older adults. Geroscience 41:89\u2013100. https:\/\/doi.org\/10.1007\/s11357-019-00056-4","journal-title":"Geroscience"},{"key":"6217_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.707840","volume":"12","author":"P Castro","year":"2021","unstructured":"Castro P, Vadera S, Bancroft MJ, Buttell J, Kaski D (2021) Case report: acute onset fear of falling and treatment with \u201ccognitive physical therapy.\u201d Front Neurol 12:707840. https:\/\/doi.org\/10.3389\/fneur.2021.707840","journal-title":"Front Neurol"},{"key":"6217_CR146","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/jnnp-2023-331537","volume":"95","author":"MC Gay","year":"2024","unstructured":"Gay MC, Cassedanne F, Barbot F, Vaugier I, Thomas S, Manchon E, Bensmail D, Blanchere M et al (2024) Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care. J Neurol Neurosurg Psychiatry 95:158\u2013166. https:\/\/doi.org\/10.1136\/jnnp-2023-331537","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6217_CR147","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7224\/1537-2073.2018-023","volume":"22","author":"ES Gromisch","year":"2020","unstructured":"Gromisch ES, Kerns RD, Czlapinski R, Beenken B, Otis J, Lo AC, Beauvais J (2020) Cognitive behavioral therapy for the management of multiple sclerosis-related pain: a randomized clinical trial. Int J MS Care 22:8\u201314. https:\/\/doi.org\/10.7224\/1537-2073.2018-023","journal-title":"Int J MS Care"},{"key":"6217_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105858","volume":"91","author":"A Lucien","year":"2024","unstructured":"Lucien A, Francis H, Wu W, Woldhuis T, Gandy M (2024) The efficacy of cognitive behavioural therapy for depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 91:105858. https:\/\/doi.org\/10.1016\/j.msard.2024.105858","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04247-9","volume":"25","author":"E Kouchaki","year":"2025","unstructured":"Kouchaki E, Bayat S, Asgarian FS (2025) Sleep disorders in patients with multiple sclerosis. BMC Neurol 25:237. https:\/\/doi.org\/10.1186\/s12883-025-04247-9","journal-title":"BMC Neurol"},{"key":"6217_CR150","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s12276-025-01397-1","volume":"57","author":"V Bos\u00e1kov\u00e1","year":"2025","unstructured":"Bos\u00e1kov\u00e1 V, Papatheodorou I, Kafka F, Tom\u00e1\u0161ikov\u00e1 Z, Kolovos P, Hortov\u00e1 Kohoutkov\u00e1 M, Fri\u010d J (2025) Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue. Exp Mol Med 57:364\u2013378. https:\/\/doi.org\/10.1038\/s12276-025-01397-1","journal-title":"Exp Mol Med"},{"key":"6217_CR151","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1749-6632.2000.tb05394.x","volume":"917","author":"J Bergquist","year":"2000","unstructured":"Bergquist J, Ohlsson B, Tarkowski A (2000) Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann N Y Acad Sci 917:281\u2013289. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05394.x","journal-title":"Ann N Y Acad Sci"},{"key":"6217_CR152","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/eji.201847525","volume":"48","author":"PM Sacramento","year":"2018","unstructured":"Sacramento PM, Monteiro C, Dias ASO, Kasahara TM, Ferreira TB, Hygino J, Wing AC, Andrade RM et al (2018) Serotonin decreases the production of Th1\/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients. Eur J Immunol 48:1376\u20131388. https:\/\/doi.org\/10.1002\/eji.201847525","journal-title":"Eur J Immunol"},{"key":"6217_CR153","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2016.01.020","volume":"292","author":"M Melnikov","year":"2016","unstructured":"Melnikov M, Belousova O, Murugin V, Pashenkov M, Boy\u043ao A (2016) The role of dopamine in modulation of Th-17 immune response in multiple sclerosis. J Neuroimmunol 292:97\u2013101. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.020","journal-title":"J Neuroimmunol"},{"key":"6217_CR154","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/glia.22772","volume":"63","author":"K Glebov","year":"2015","unstructured":"Glebov K, L\u00f6chner M, Jabs R, Lau T, Merkel O, Schloss P, Steinh\u00e4user C, Walter J (2015) Serotonin stimulates secretion of exosomes from microglia cells. Glia 63:626\u2013634. https:\/\/doi.org\/10.1002\/glia.22772","journal-title":"Glia"},{"key":"6217_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103522","volume":"58","author":"\u0395 Stamoula","year":"2022","unstructured":"Stamoula \u0395, Ainatzoglou A, Stamatellos VP, Dardalas I, Siafis S, Matsas A, Stamoulas K, Papazisis G (2022) Atypical antipsychotics in multiple sclerosis: a review of their in vivo immunomodulatory effects. Mult Scler Relat Disord 58:103522. https:\/\/doi.org\/10.1016\/j.msard.2022.103522","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR156","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2017.10.012","volume":"313","author":"R Bhat","year":"2017","unstructured":"Bhat R, Mahapatra S, Axtell RC, Steinman L (2017) Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol 313:77\u201381. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.10.012","journal-title":"J Neuroimmunol"},{"key":"6217_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.920408","volume":"13","author":"M Melnikov","year":"2022","unstructured":"Melnikov M, Kasatkin D, Lopatina A, Spirin N, Boyko A, Pashenkov M (2022) Serotonergic drug repurposing in multiple sclerosis: a new possibility for disease-modifying therapy. Front Neurol 13:920408. https:\/\/doi.org\/10.3389\/fneur.2022.920408","journal-title":"Front Neurol"},{"key":"6217_CR158","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA (2023) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry 28:3243\u20133256. https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"key":"6217_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104920","volume":"78","author":"O Belousova","year":"2023","unstructured":"Belousova O, Lopatina A, Kuzmina U, Melnikov M (2023) The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammation. Mult Scler Relat Disord 78:104920. https:\/\/doi.org\/10.1016\/j.msard.2023.104920","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01026","volume":"13","author":"Z Bai","year":"2019","unstructured":"Bai Z, Chen D, Wang L, Zhao Y, Liu T, Yu Y, Yan T, Cheng Y (2019) Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients. Front Neurosci 13:1026. https:\/\/doi.org\/10.3389\/fnins.2019.01026","journal-title":"Front Neurosci"},{"key":"6217_CR161","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","volume":"8","author":"SM Smith","year":"2006","unstructured":"Smith SM, Vale WW (2006) The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383\u2013395. https:\/\/doi.org\/10.31887\/DCNS.2006.8.4\/ssmith","journal-title":"Dialogues Clin Neurosci"},{"key":"6217_CR162","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5350\/DAJPN2017300102","volume":"30","author":"Y Hacimusalar","year":"2017","unstructured":"Hacimusalar Y, Esel E (2017) Evaluation of hypothalamo-pituitary-adrenal axis activity by using dexamethasone suppression test in patients with panic disorder and generalized anxiety disorder. Dusunen Adam J Psychiatry Neurol Sci 30:15\u201324","journal-title":"Dusunen Adam J Psychiatry Neurol Sci"},{"key":"6217_CR163","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.biopsych.2007.07.002","volume":"63","author":"C Heim","year":"2008","unstructured":"Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB (2008) The dexamethasone\/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry 63:398\u2013405. https:\/\/doi.org\/10.1016\/j.biopsych.2007.07.002","journal-title":"Biol Psychiatry"},{"key":"6217_CR164","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-013-1140-7","volume":"126","author":"J Melief","year":"2013","unstructured":"Melief J, de Wit SJ, van Eden CG, Teunissen C, Hamann J, Uitdehaag BM, Swaab D, Huitinga I (2013) HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathol 126:237\u2013249. https:\/\/doi.org\/10.1007\/s00401-013-1140-7","journal-title":"Acta Neuropathol"},{"key":"6217_CR165","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ana.10187","volume":"51","author":"EM Schumann","year":"2002","unstructured":"Schumann EM, K\u00fcmpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP (2002) Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol 51:763\u2013767. https:\/\/doi.org\/10.1002\/ana.10187","journal-title":"Ann Neurol"},{"key":"6217_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14175984","volume":"14","author":"CI Aviles Gonzalez","year":"2025","unstructured":"Aviles Gonzalez CI, Barrui V, Migliaccio GM, Curcio F, Gioiello G, Romero Z, Ivziku D, Machado S et al (2025) Gender differences in the perceived impact of major depressive disorder on quality of life: a cross-sectional population study. J Clin Med 14:5984. https:\/\/doi.org\/10.3390\/jcm14175984","journal-title":"J Clin Med"},{"key":"6217_CR167","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.jcp.0000168879.03169.ce","volume":"25","author":"A Khan","year":"2005","unstructured":"Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA (2005) Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 25:318\u2013324. https:\/\/doi.org\/10.1097\/01.jcp.0000168879.03169.ce","journal-title":"J Clin Psychopharmacol"},{"key":"6217_CR168","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2018","unstructured":"Sintzel MB, Rametta M, Reder AT (2018) Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther 7:59\u201385. https:\/\/doi.org\/10.1007\/s40120-017-0086-4","journal-title":"Neurol Ther"},{"key":"6217_CR169","doi-asserted-by":"publisher","first-page":"3483411","DOI":"10.1155\/2023\/3483411","volume":"2023","author":"VTA Thu","year":"2023","unstructured":"Thu VTA, Hoang TX, Kim JY (2023) 1,25-Dihydroxy vitamin D3 facilitates the M2 polarization and \u03b2-amyloid uptake by human microglia in a TREM2-dependent manner. Biomed Res Int 2023:3483411. https:\/\/doi.org\/10.1155\/2023\/3483411","journal-title":"Biomed Res Int"},{"key":"6217_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1498","volume":"10","author":"U Gomez-Pinedo","year":"2020","unstructured":"Gomez-Pinedo U, Cuevas JA, Benito-Mart\u00edn MS, Moreno-Jim\u00e9nez L, Esteban-Garcia N, Torre-Fuentes L, Mat\u00edas-Guiu JA, Pytel V et al (2020) Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation. Brain Behav 10:e01498. https:\/\/doi.org\/10.1002\/brb3.1498","journal-title":"Brain Behav"},{"key":"6217_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02705-0","volume":"20","author":"P Cui","year":"2023","unstructured":"Cui P, Lu W, Wang J, Wang F, Zhang X, Hou X, Xu F, Liang Y et al (2023) Microglia\/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model. J Neuroinflammation 20:63. https:\/\/doi.org\/10.1186\/s12974-023-02705-0","journal-title":"J Neuroinflammation"},{"key":"6217_CR172","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","volume":"175","author":"KM Spach","year":"2005","unstructured":"Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175:4119\u20134126. https:\/\/doi.org\/10.4049\/jimmunol.175.6.4119","journal-title":"J Immunol"},{"key":"6217_CR173","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.2025.1604","volume":"333","author":"E Thouvenot","year":"2025","unstructured":"Thouvenot E, Laplaud D, Lebrun-Frenay C, Derache N, Le Page E, Maillart E, Froment-Tilikete C, Castelnovo G et al (2025) High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-Lay MS randomized clinical trial. JAMA 333:1413\u20131422. https:\/\/doi.org\/10.1001\/jama.2025.1604","journal-title":"JAMA"},{"key":"6217_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106567","volume":"101","author":"E Gomez-Figueroa","year":"2025","unstructured":"Gomez-Figueroa E, Moreno-Bernardino C, B\u00e4cker-Koduah P, D\u00f6rr J, Rubarth K, Konietschke F, Bellmann-Strobl J, Ruprecht K et al (2025) Neuroprotective role of high dose vitamin D supplementation in multiple sclerosis: sub-analysis of the EVIDIMS trial. Mult Scler Relat Disord 101:106567. https:\/\/doi.org\/10.1016\/j.msard.2025.106567","journal-title":"Mult Scler Relat Disord"},{"key":"6217_CR175","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","volume":"36","author":"M Ben Nasr","year":"2024","unstructured":"Ben Nasr M, Usuelli V, Dellepiane S, Seelam AJ, Fiorentino TV, D\u2019Addio F, Fiorina E, Xu C et al (2024) Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metab 36:1302-1319.e12. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.001","journal-title":"Cell Metab"},{"key":"6217_CR176","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.7150\/ijbs.68974","volume":"18","author":"Z Qian","year":"2022","unstructured":"Qian Z, Chen H, Xia M, Chang J, Li X, Ye S, Wu S, Jiang S et al (2022) Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury. Int J Biol Sci 18:1328\u20131346. https:\/\/doi.org\/10.7150\/ijbs.68974","journal-title":"Int J Biol Sci"},{"key":"6217_CR177","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbrc.2012.07.086","volume":"425","author":"D Shiraishi","year":"2012","unstructured":"Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M (2012) Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation. Biochem Biophys Res Commun 425:304\u2013308. https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.086","journal-title":"Biochem Biophys Res Commun"},{"key":"6217_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00914-3","volume":"12","author":"I Singh","year":"2022","unstructured":"Singh I, Wang L, Xia B, Liu J, Tahiri A, El Ouaamari A, Wheeler MB, Pang ZP (2022) Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake. Cell Biosci 12:178. https:\/\/doi.org\/10.1186\/s13578-022-00914-3","journal-title":"Cell Biosci"},{"key":"6217_CR179","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cmet.2020.05.001","volume":"31","author":"K Timper","year":"2020","unstructured":"Timper K, Del R\u00edo-Mart\u00edn A, Cremer AL, Bremser S, Alber J, Giavalisco P, Varela L, Heilinger C et al (2020) GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function. Cell Metab 31:1189-1205.e13. https:\/\/doi.org\/10.1016\/j.cmet.2020.05.001","journal-title":"Cell Metab"},{"key":"6217_CR180","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s13311-021-01088-5","volume":"18","author":"M Gharagozloo","year":"2021","unstructured":"Gharagozloo M, Smith MD, Sotirchos ES, Jin J, Meyers K, Taylor M, Garton T, Bannon R et al (2021) Therapeutic potential of a novel glucagon-like peptide-1 receptor agonist, NLY01, in experimental autoimmune encephalomyelitis. Neurotherapeutics 18:1834\u20131848. https:\/\/doi.org\/10.1007\/s13311-021-01088-5","journal-title":"Neurotherapeutics"},{"key":"6217_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109647","volume":"115","author":"MA Sadek","year":"2023","unstructured":"Sadek MA, Kandil EA, El Sayed NS, Sayed HM, Rabie MA (2023) Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway. Int Immunopharmacol 115:109647. https:\/\/doi.org\/10.1016\/j.intimp.2022.109647","journal-title":"Int Immunopharmacol"},{"key":"6217_CR182","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/ijms20071584","volume":"20","author":"HC Chiou","year":"2019","unstructured":"Chiou HC, Lin MW, Hsiao PJ, Chen CL, Chiao S, Lin TY, Chen YC, Wu DC et al (2019) Dulaglutide modulates the development of tissue-infiltrating Th1\/Th17 cells and the pathogenicity of encephalitogenic Th1 cells in the central nervous system. Int J Mol Sci 20:1584. https:\/\/doi.org\/10.3390\/ijms20071584","journal-title":"Int J Mol Sci"},{"key":"6217_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108824","volume":"269","author":"A Arredouani","year":"2025","unstructured":"Arredouani A (2025) GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders? Pharmacol Ther 269:108824. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108824","journal-title":"Pharmacol Ther"},{"key":"6217_CR184","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner WG, Remy P, Giordana C, Malt\u00eate D, Derkinderen P, Hou\u00e9to JL, Anheim M, Benatru I et al (2024) Trial of lixisenatide in early Parkinson\u2019s disease. N Engl J Med 390:1176\u20131185. https:\/\/doi.org\/10.1056\/NEJMoa2312323","journal-title":"N Engl J Med"},{"key":"6217_CR185","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00415-025-13301-y","volume":"272","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang C, Wang Y, Wang T (2025) Clinical efficacy of GLP-1 receptor agonists in the treatment of Parkinson\u2019s disease: a systematic review and meta-analysis of randomizeds controlled trials. J Neurol 272:555. https:\/\/doi.org\/10.1007\/s00415-025-13301-y","journal-title":"J Neurol"},{"key":"6217_CR186","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","volume":"32","author":"DJ Drucker","year":"2026","unstructured":"Drucker DJ (2026) The expanding landscape of GLP-1 medicines. Nat Med 32:47\u201357. https:\/\/doi.org\/10.1038\/s41591-025-04124-5","journal-title":"Nat Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06217-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:58:10Z","timestamp":1789804690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":186,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6217"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06217-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study does not involve human participants or animal experiments.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"907"}}